Table 1.
Serial changes in laboratory and clinical indices over the 6-month treatment period
| Variables | Pre-treatment | After 3 months | After 6 months |
|---|---|---|---|
| Systolic/diastolic blood pressure, mmHg | 130/82 | 128/80 | 128/80 |
| Low-density lipoprotein cholesterol, mg/dL | 126 | 124 | 122 |
| High-density lipoprotein cholesterol, mg/dL | 66 | 68 | 66 |
| Triglyceride, mg/dL | 98 | 100 | 100 |
| Serum creatinine, mg/dL | 1.32 | 1.30 | 1.28 |
| Blood urea nitrogen, mg/dL | 22 | 22 | 20 |
| Uric acid, mg/dL | 9.2 | 7.4 | 6.4 |
| Urinary albumin excretion, mg/g.cr | 388.6 | 288.2 | 88.4 |
| Liver-type fatty acid-binding protein, µg/g.cr | 28.8 | 24.2 | 19.8 |
| Flow-mediated dilation, % | 5.4 | 5.6 | 5.8 |